Low-density lipoprotein subfraction profiles in chronic renal failure

被引:61
|
作者
Rajman, I
Harper, L
McPake, D
Kendall, MJ
Wheeler, DC
机构
[1] Queen Elizabeth Hosp, Clin Invest Unit, Birmingham B15 2TH, W Midlands, England
[2] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TH, W Midlands, England
关键词
LDL subfractions; renal failure; transplants;
D O I
10.1093/ndt/13.9.2281
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Small low-density lipoprotein (LDL) particle size, a newly recognized risk factor for cardiovascular disease in the general population, is frequently associated with hypertriglyceridaemia, the predominant plasma lipid abnormality present in uraemia. Methods. Plasma lipids and LDL subfraction profiles were examined in 33 non-dialysed patients with chronic renal failure (predial), 40 patients on continuous ambulatory peritoneal dialysis (CAPD), 42 haemodialysis patients (HD), 47 renal transplant recipients (RTR), and 44 controls. LDL subfractions separated by gel electrophoresis were scored by densitometric analysis (higher scores indicate profiles comprising smaller particles). Results. All groups with renal failure had significantly elevated (mean +/- SD) LDL scores (predial 1.36 +/- 0.6, CAPD 1.71 +/- 0.9, HD 1.68 +/- 0.9, RTR 1.92 +/- 0.8 vs control 0.87 +/- 0.4, all P < 0.001), this being the only lipid abnormality detected in the predialysis patients. In CAPD and HD patients, LDL scores were associated with serum triglyceride (r = 0.81, P < 0.001 and r = 0.70, P < 0.001 respectively), cholesterol (r = 0.55, P < 0.001 and r = 0.49, P < 0.01) and HDL-cholesterol (r = -0.43, P < 0.01 and r = -0.51, P < 0.01), whilst no such relationship was seen in the predialysis and RTR groups, suggesting that other factors were important. Conclusions. The presence of small LDL particles appears to be an early and unexplained feature of the uraemic dyslipidaemia. This abnormality persists after renal transplantation and may represent an important atherogenic risk factor.
引用
收藏
页码:2281 / 2287
页数:7
相关论文
共 50 条
  • [31] Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction
    Benítez, S
    Sánchez-Quesada, JL
    Ribas, V
    Jorba, O
    Blanco-Vaca, F
    González-Sastre, F
    Ordóñez-Llanos, J
    CIRCULATION, 2003, 108 (01) : 92 - 96
  • [32] IS HYPERTRIGLYCERIDEMIC VERY LOW-DENSITY LIPOPROTEIN A PRECURSOR OF NORMAL LOW-DENSITY LIPOPROTEIN
    OSCHRY, Y
    EISENBERG, S
    DECKELBAUM, R
    OLIVECRONA, T
    ARTERIOSCLEROSIS, 1982, 2 (05): : A442 - A442
  • [33] Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol
    Moriyama, Kengo
    Takahashi, Eiko
    CLINICAL LABORATORY, 2017, 63 (7-8) : 1179 - 1186
  • [34] IS HYPERTRIGLYCERIDEMIC VERY LOW-DENSITY LIPOPROTEIN A PRECURSOR OF NORMAL LOW-DENSITY LIPOPROTEIN
    OSCHRY, Y
    OLIVECRONA, T
    DECKELBAUM, RJ
    EISENBERG, S
    JOURNAL OF LIPID RESEARCH, 1985, 26 (02) : 158 - 167
  • [35] Low-density lipoprotein and oxidised low-density lipoprotein: Their role in the development of atherosclerosis
    Hamilton, CA
    PHARMACOLOGY & THERAPEUTICS, 1997, 74 (01) : 55 - 72
  • [36] MECHANISMS OF LIPOPROTEIN INTERCONVERSIONS - FORMATION OF LOW-DENSITY LIPOPROTEIN FROM VERY LOW-DENSITY LIPOPROTEIN
    EISENBERG, S
    ARTERY, 1975, 1 (03) : 205 - 205
  • [37] Direct measurement of low-density lipoprotein in diabetic patients with end-stage renal failure
    Banks, M.
    Wilson, G.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2007, 64 (04) : 175 - 175
  • [38] Regulation of low-density lipoprotein (LDL) subfractions in end-stage renal failure (ESRF).
    Deighan, CJ
    Caslake, MJ
    McConnell, M
    Boulton-Jones, JM
    Packard, CJ
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2561 - 2561
  • [39] Low-Density Lipoprotein Subfraction Phenotype Is Associated with Epicardial Adipose Tissue Volume in Type 2 Diabetes
    Rives, Jose
    Gil-Millan, Pedro
    Vilades, David
    Garcia-Osuna, Alvaro
    Genua, Idoia
    Minambres, Inka
    Grau-Agramunt, Margarida
    Gich, Ignasi
    Puig, Nuria
    Benitez, Sonia
    Julve, Josep
    Perez, Antonio
    Sanchez-Quesada, Jose Luis
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [40] Pravastatin improves low-density lipoprotein oxidation in renal transplantation
    Cofan, F
    Zambon, D
    Laguna, JC
    Casals, E
    Ros, E
    Cofan, M
    Campistol, JM
    Oppenheimer, F
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 389 - 391